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Background:  Prinzmetal’s  angina  is characterized  by  a transient  reduction  in  luminal  diameter  of  a  coro-
nary  artery  resulting  in  spontaneous  and  often  recurrent  episodes  of  angina  with  electrocardiography
(ECG)  ﬁndings  consistent  with  ST elevation.
Case report:  A  67-year-old  male  presented  with  complaint  of intermittent  chest discomfort  during  the
previous  2–3 weeks.  ECG  obtained  at presentation  was  consistent  with  ST  elevation  in inferior  leads.  The
patient  underwent  urgent  cardiac  catheterization  with  uncomplicated  balloon  angioplasty  to proximal
and  distal  right  coronary  artery  (RCA).  At  two-week  follow  up,  the  patient  continued  to complain  of  recur-
rent  chest  discomfort  with  repeat  ECG  showing  ST elevation  in  inferior  leads.  He  was  given  nitroglycerin
with  symptomatic  improvement  and  gradual  resolution  of  ST  elevation.  Given  concern  for  reocclusion,  the
patient  again  underwent  urgent  cardiac  catheterization  showing  subtotal  occlusion  of  the  proximal  RCA.
During  the  procedure,  intracoronary  nitroglycerin  was  administered  with  visible  resolution  of the  occlu-
sion  via  angiography  consistent  with  coronary  vasospasm.  The  patient  was  therefore  initiated  on therapy
with  amlodipine  and  isosorbide  mononitrate  and  remained  symptom  free  at subsequent  follow-up
visits.
Conclusion:  Prinzmetal’s  angina  is a  well-documented  but under-recognized  etiology  of  recurrent  ST
elevation  myocardial  infarction  which  should  be considered  in those  with  both  typical  and  atypical
cardiovascular  risk  proﬁles.
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Prinzmetal’s angina or variant angina (VA) is characterized by
 transient reduction in the luminal diameter of a coronary artery
esulting in spontaneous and often recurrent episodes of angina
ith transient ST elevation on electrocardiogram (ECG). The attack
f VA occurs at rest or during ordinary activity and is not precip-
tated by strenuous exercise [1]. ECG ﬁndings with ST elevation
ften result in urgent cardiac catheterization especially for those
ith notable cardiovascular risk factors in which VA may  not be
nitially suspected. Here, we present a case of VA resulting in
ecurrent cardiac catheterization to evaluate chest pain with ST
levation.
ase reportA  67-year-old African American male with past medical history
igniﬁcant for hypertension, hyperlipidemia, chronic obstructive
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pulmonary disease, and tobacco use presented to his primary care
physician with complaint of intermittent chest discomfort during
the previous 2–3 weeks. The pain was described as a subster-
nal pressure which was  non-radiating and occurred daily lasting
for 5–15 min per episode. The pain occurred spontaneously and
was not associated with exertion. Home medications included
hydrochlorothiazide and lisinopril. He did not have a signiﬁcant
family history for premature coronary artery disease. ECG at pre-
sentation was  consistent with ST elevation in the inferior leads.
The patient was  immediately transferred to the emergency depart-
ment with subsequent urgent cardiac catheterization notable for
90% proximal and 90% distal right coronary artery (RCA) lesions and
underwent uncomplicated balloon angioplasty without stenting.
Of note, the patient had a peak troponin of 0.02 g/L and ejec-
tion fraction (EF) of 65% with mild inferior wall hypokinesis by left
ventriculography. He was discharged on aspirin, clopidogrel, meto-
prolol, simvastatin, lisinopril, and nitroglycerin as needed for chest
pain.
At two-week follow up with cardiology, the patient com-
plained of having recurrent chest pain mostly in the morning
since the time of discharge. He also developed similar chest
discomfort in the morning on the day of his appointment. It
was 7/10 in intensity and reduced to 5/10 in clinic. His blood
vier Ltd. All rights reserved.
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Fig. 1. Electrocardiogram 1: on initial presentation showing ST elevation in leads II, III, and aVF.
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tressure was 143/85 mmHg  and ECG showed 3 mm ST elevation
n leads II, III, and aVF and reciprocal ST depression in leads I and
VL. The patient was given nitroglycerin after which his blood
ressure reduced to 123/78 mmHg  and repeat ECG showed grad-
al decrease in ST elevations with symptomatic improvement
n the chest discomfort (Figs. 1 and 2). The patient was  taken
ack for cardiac catheterization due to concern for reocclusion
f RCA.
Repeat cardiac catheterization showed subtotal occlusion of
roximal RCA. During the procedure, he was given intracoronary
itroglycerin with visible resolution of the occlusion consistent
ith coronary vasospasm (Figs. 3 and 4). EF was  65% with no wall
otion changes on cardiac catheterization. As the repeat catheter-zation had occlusion at the same location, it was perceived that
asospasm must have been the cause during the ﬁrst event. No
ntracoronary nitroglycerin was used during the ﬁrst catheteriza-
ion. Following this, he was diagnosed with VA and was started
Fig. 2. Electrocardiogram 2: 30 min  after sublingual nitroglycerin on  amlodipine and isosorbide mononitrate as vasodilator ther-
apy. The patient remained symptom free on subsequent follow-up
visits.
Discussion
The key ﬁnding for the diagnosis of coronary vasospasm
includes simultaneous resolution of ST segment changes and angi-
nal symptoms spontaneously or with nitroglycerin, or reversibility
of coronary occlusions upon intraluminal injections of nitroglycerin
during cardiac catheterization. Yasue et al. [2] suggested the diag-
nostic criteria for VA without performing coronary angiography if
anginal attacks disappear quickly upon administration of nitroglyc-
erin and if any one of following criteria were met: (1) attacks appear
at rest, particularly between night and early morning; (2) reduction
in exercise capacity in the early morning; (3) attacks accompa-
nied by ST segment elevation on ECG; (4) attacks are induced by
showing gradual resolution of ST segments in inferior leads.
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Fig. 3. Coronary angiogram with evidence of luminal narrowing of the right coro-
nary artery.
F
f
h
b
n
[
d
i
a
[
[
[
[
[
[ig. 4. Coronary angiogram showing normalization of the right coronary artery
ollowing  intracoronary nitroglycerin suggesting coronary vasospasm.
yperventilation; (5) attacks are suppressed by calcium channel
lockers but not by beta-blockers. This has been included in diag-
ostic criteria for VA by the Japanese Society of Circulation 2008
3].Female gender, relatively younger age, smoking, magnesium
eﬁciency, lipid abnormalities, stress, and genetic factors are
mportant risk factors [4]. Genetic factors play an important role
s seen by three times higher prevalence of VA in Asian countries
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like  Japan compared to Western countries. The exact pathogenesis
is unclear but various studies have shown increased vagal activity
and hyperactivity to adrenergic system before the attacks [5]. Also
endothelial dysfunction and decrease in smooth muscle relaxation
may result in vasospasm.
Patients  with VA show ST segment elevation and reciprocal
depression on ECG during attacks of chest pain. Ambulatory ECG
monitoring in patients with VA showed circadian variation with
most of the ischemic episodes occurring between midnight to early
morning hours with peak frequency around 05.00 h [6]. Another
important feature of VA is the frequency of asymptomatic ischemic
episodes being much higher than symptomatic episodes. One study
revealed that 82% (872 out of 1062) of episodes were asymptomatic
[6]. Severe arrhythmias, including ventricular tachycardia, high-
degree atrioventricular block, and bradyarrythmias resulting in
syncopal episodes may  be occasionally seen during an attack of
VA. Patients with recurrent chest pain with normal coronaries on
angiography should be considered for Holter or ambulatory ECG
monitoring to detect asymptomatic ischemic changes from VA [4].
Medical treatment for VA includes cardiovascular risk factor
reduction and vasodilators including calcium-channel blockers and
nitrates. In resistant cases, addition of magnesium supplements,
statins, antioxidants, and fasudil, a Rho-kinase inhibitor, prevent
coronary vasospasm [7].
Conclusion
Printzmetal’s  angina/VA is a well-documented etiology of recur-
rent ST elevation myocardial infarction which should be considered
in patients with and without typical cardiovascular risk proﬁles to
avoid repeat invasive studies.
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